Advertisement
OtherDrug Discovery and Translational Medicine

Treatment of γ-Hydroxybutyrate (GHB) Overdose with the GABAB Antagonist SGS742

Kristin E Follman and Marilyn E. Morris
Journal of Pharmacology and Experimental Therapeutics May 3, 2022, JPET-AR-2022-001108; DOI: https://doi.org/10.1124/jpet.122.001108

Article Information

JPET-AR-2022-001108
DOI 
https://doi.org/10.1124/jpet.122.001108
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online May 3, 2022.
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kristin E Follman1 and
  2. Marilyn E. Morris1,*
  1. 1Pharmaceutical Sciences, University at Buffalo, United States
  1. ↵* Corresponding Author:
    Marilyn E. Morris, Pharmaceutical Sciences, University at Buffalo, Dept. of Pharmaceutical Sciences, 304 Pharmacy Building, University at Buffalo, State Univ. of New York, Buffalo, New York, 14214-8033, United States. E-mail: memorris{at}buffalo.edu

Statistics from Altmetric.com

Article usage

Article usage: May 2022 to May 2022

AbstractFullPdf
May 2022173096

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherDrug Discovery and Translational Medicine

SGS742 and Treatment of GHB Overdoses

Kristin E Follman and Marilyn E. Morris
Journal of Pharmacology and Experimental Therapeutics May 3, 2022, JPET-AR-2022-001108; DOI: https://doi.org/10.1124/jpet.122.001108
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement